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outcomes of necrotizing fasciitis in New Zealand:
a retrospective chart review
Dilip Kumar Das1,2*, Michael G Baker1 and Kamalesh Venugopal1Abstract
Background: The incidence and mortality from necrotizing fasciitis (NF) are increasing in New Zealand (NZ).
Triggered by a media report that traditional Samoan tattooing was causing NF, we conducted a chart review to
investigate the role of this and other predisposing and precipitating factors and to document NF microbiology,
complications and interventions in NZ.
Methods: We conducted a retrospective review of 299 hospital charts of patients discharged with NF diagnosis
codes in eight hospitals in NZ between 2000 and 2006. We documented and compared by ethnicity the
prevalence of predisposing and precipitating conditions, bacteria isolated, complications and interventions used.
Results: Out of 299 charts, 247 fulfilled the case definition. NF was most common in elderly males. Diabetes was
the most frequent co-morbid condition, followed by obesity. Nearly a quarter of patients were taking non-steroidal
anti-inflammatory drugs (NSAID). Traditional Samoan tattooing was an uncommon cause. Streptococcus pyogenes
and Staphylococcus aureus were the two commonly isolated bacteria. Methicillin-resistant Staphylococcus aureus was
implicated in a relatively small number of cases. Shock, renal failure, coagulation abnormality and multi-organ
dysfunction were common complications. More than 90% of patients underwent surgical debridement, 56% were
admitted to an intensive care unit (ICU) and slightly less than half of all patients had blood product transfusion.
One in six NF cases had amputations and 23.5% died.
Conclusion: This chart review found that the highest proportion of NF cases was elderly males with co-morbidities,
particularly diabetes and obesity. Tattooing was an uncommon precipitating event. The role of NSAID needs further
exploration. NF is a serious disease with severe complications, high case fatality and considerable use of health care
resources.
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Necrotizing fasciitis (NF) is a rapidly progressive soft tis-
sue infection characterized by necrosis of the subcutane-
ous tissue and fascia [1,2]. Although rare, NF frequently
causes severe illness resulting in death or permanent
disability [2]. Analysis of hospitalization data in New
Zealand (NZ) for the period 1990 to 2006 showed that
incidence and mortality rates of NF have increased* Correspondence: dilipdas5591@gmail.com
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reproduction in any medium, provided the orsignificantly and the incidence is significantly higher in
Pacific people and Maori than in Europeans and people
of Other ethnicity [3]. The causes of the increase and
differential ethnic distribution in incidence are not
known [3].
The pathogenesis of NF involves a complex interplay
between agent and host factors. Most patients who
develop NF have pre-existing conditions that render
them susceptible to infection [4], although it also occurs
in young, previously healthy individuals [2,5]. The dis-
ease occurs more frequently in the elderly [4,6,7], dia-
betics [4,6-10], alcoholics [6-8], intravenous drug users
[2,4,6,11], in patients with chronic liver disease [2], renal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gout [8,12], underlying malignancy [4,6,7] or immuno-
compromised states [4,6]. Other factors which have been
found to be associated with NF are obesity [4,6], malnu-
trition [4,6], chronic obstructive pulmonary diseases
[7,9] and congestive heart failure [9]. Many NF patients
are found to be taking non-steroidal anti-inflammatory
drugs (NSAID) at the time of presentation to hospital
[9,12,13], but its role remains unclear [14,15].
Usually the disease is precipitated by some form of
injury or local pathological condition [7]. Blunt or
penetrating trauma [4], operation site infection [4],
burn [4], ulcers [16], abscess [16] and even child birth
[4] have been documented as precipitating factors
for NF. Body piercing procedures such as acupunc-
ture [6] and tattooing [17], very minor trauma such
as abrasion [16] and insect bites [16] have also been
found to initiate NF. In some situations NF has arisen
without identifiable antecedent trauma [7,16] or patho-
logical state [7].
Tattooing and skin piercing are invasive procedures
and can have infective complications if not done in a
sterile way [18,19]. A few cases of NF and severe soft tis-
sue infection following traditional Samoan tattooing
have been reported in NZ [17,20] drawing wide media
attention [21].
NF may be caused by a variety of aerobic and faculta-
tive anaerobic bacteria, including Streptococcus pyogenes
or group A streptococci (GAS), Staphylococcus aureus,
Escherichia coli, Clostridium and Bacteroides species [1].
Rarely, group B, C, and G streptococci, Haemophilus
influenzae type b, Pseudomonas aeruginosa,Vibrio vulni-
ficus, and fungi are involved [1]. Frequently the disease
is polymicrobial [16,22]. The microbiology of NF in NZ
has not been well documented.
Managing NF uses a large amount of health-care
resources [23]. It can also cause serious complications
[23], such as acute renal failure, shock, multi-organ dys-
function, coagulopathy, arrhythmia, and myocardial in-
farction. Its management requires intensive care unit
(ICU) admission in many cases, and urgent surgical de-
bridement and intravenous antibiotics in almost all cases
[1,2,24]. Many patients who survive require reconstruct-
ive surgery and skin grafting (often with multiple admis-
sions) [25]. Blood product transfusion and dialysis are
also needed to manage specific complications. The dis-
ease is associated with a high case fatality risk and per-
manent disability in the form of limb loss [26].
We conducted a retrospective chart review to investi-
gate the relationship between the incidence of NF in NZ
and traditional Samoan tattooing and other risk factors,
and to document the microbiology, complications, treat-
ment and outcomes of NF. A particular focus was to
compare these characteristics across ethnic groups.Methods
To explore the role of traditional Samoan tattooing in
NF, we purposely selected hospitals with NF patients of
Pacific ethnicity for chart review. From Ministry of Health
hospital discharge data for the period 2000–2006, we
identified hospitals where at least one person of Pacific
ethnicity was admitted with NF during this period. These
hospitals were: Auckland City, Starship, North Shore,
Middlemore, Tauranga, Rotorua, Hutt and Wellington.
These hospitals included 58% of the 513 cases discharged
from NZ hospitals with an NF diagnosis over that seven
year period.
By using the International Classification of Diseases
(ICD) codes of NF (M7250 to M7269 in ICD-10-AM
versions 1, 2 and 3) we identified the National Health
Index (NHI) numbers of all NF patients (all ethnicities)
in these hospitals admitted between 2000 and 2006 and
subsequently located their charts.
One investigator (DD) visited Medical Records Depart-
ments of the above mentioned hospitals and extracted
relevant data from patients’ charts and entered these into
a Microsoft Access database.
A case was included in the chart review if it satisfied
the following criteria:
 Discharge diagnosis of NF (M7250 – M7269 in
ICD-10), irrespective of whether NF was the
principal diagnosis or an additional diagnosis; AND
 Operation notes clearly indicated presence of
necrosis in the fascia and subcutaneous tissue; OR
 Operative finding specifically mentioned ‘necrotizing
fasciitis’; OR
 Histopathology of debrided fascia and subcutaneous
tissue or autopsy findings of local tissue showed
necrosis.
If the case has been coded as ‘NF’ or as ‘Fasciitis, Not
Elsewhere Classified,’ but the operative or histopathology
or autopsy criteria were not satisfied, the chart was not
reviewed further.
We checked the data for any inconsistencies and out-
liers and corrected these in the data preparation stage.
Frequency tables of variables of interest were generated.
Tests of statistical significance were done using the Chi-
square test. We used level 1 prioritized ethnicity and
four ethnic groupings: European, Maori, Pacific and
Other (including Asian) [27]. Data were analyzed using
Statistical Package for the Social Sciences for Windows
version 9 (SPSS Inc., Chicago, IL) and Epi Info™ version 6
(Centers for Disease Control and Prevention, Atlanta,
GA).
Multi-Region Ethics Committee approval was obtained
to access, review and extract the relevant data from NF
patients’ charts from the selected hospitals.
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Patients included
We reviewed 299 NF patient charts of which 247
(82.6%) satisfied the case inclusion criteria. Conditions
like diabetic gangrene of toe, foot and leg, cellulitis, ab-
scess, plantar fasciitis, Dupuytren’s contracture, and limb
loss due to invasive meningococcal disease were some-
times coded as fasciitis or NF. However, these were
clearly not cases of NF and were excluded from the ana-
lysis. Operative and histology findings criteria were the
two most commonly used criteria for assigning disease
status. However, for more than half of the charts a hist-
ology report was not available. Many operative notes did
not mention specific operative findings but just men-
tioned ‘NF found at operation’. Consequently, a very
tight case definition could not always be applied.
Demography of reviewed patients
Table 1 shows the age, sex and ethnicity distribution of
the 247 NF cases fulfilling the case definition. Males
comprised 61% and females 39% of the total. Amongst
Europeans the highest number of cases was in the 70+
age group, while for Maori and people of Pacific and
Other ethnicity, the number of cases was highest in the
50–69 year age group. The median age of European
cases (61.4 years) was significantly higher than Maori
(48.9 years) and Pacific (50.8 years) (p < 0.001).
Predisposing conditions
Table 2 shows the ethnic distribution of selected predis-
posing conditions. Diabetes was the most common
(32.0%) predisposing condition, followed by obesity
(22.7%). Nearly a quarter of the patients (23.1%) were
reported to have taken NSAID within the seven days
preceding development of NF. About a fifth of the
patients did not have any predisposing condition
recorded in their charts.
Some conditions were comparatively more prevalent
in particular ethnic groups, e.g., diabetes in Others andTable 1 Age, sex and ethnicity distribution of NF patients rev
Age European Maori
group (years) (n=122) (n=47)
M F M F
0-14 2 1 1 2
15-29 3 3 5 3
30-49 17 11 11 5
50-69 25 15 10 7
70+ 24 21 2 1
Total* 71 51 29 18
(%) (58.2) (41.8) (61.7) (38.3)
M – Male, F – Female. *Total includes one male case with ‘unknown’ ethnicity.Pacific people, alcohol abuse in Europeans, obesity in Maori
and Pacific people, coronary heart disease in Others, con-
gestive heart failure in Pacific people, chronic obstructive
pulmonary disease (COPD) in Europeans, cancers in
Others and Europeans, steroid use in Europeans, NSAID
use in Others and chronic renal failure in Maori. However,
the ethnic difference in prevalence was significant only for
diabetes (p < 0.01) and steroid use (p < 0.05). P-values in
this and subsequent tables should be interpreted with
caution where some cells have values <5. There was also
a statistically significant difference (p 0.004) in the ethnic
distribution of cases with ‘no condition documented’
(Table 2). From the available clinical notes it is not
possible to say the cause of this association. The signifi-
cantly greater age of the European cases may have con-
tributed to the higher documented prevalence of co-
morbidities for NF cases from that ethnic group.Precipitating events
The distribution of precipitating events by ethnicity is
shown in Table 3. By far the most commonly reported
precipitating event was accidental trauma (33.2%), fol-
lowed by skin ulcer (15.8%) and surgery (11.3%). The
type of trauma ranged from superficial graze to blunt
trauma without skin break, laceration and penetrating
injuries. This group also included insect and animal
bites. Five patients had a history of insect bite (one mos-
quito, one sand fly and three unspecified insect bites) as
precipitating events. One person developed NF following
a dog bite on their leg.
Only four patients (1.6% of the total) developed NF
directly following traditional Samoan tattooing. All of
them were Samoan and one of them died. Not surpris-
ingly, the p value of this category indicates statistically
significant ethnic differences in exposure to this pre-
cipitating event (Table 3). Two people (0.8%) were
noted to have acupuncture in the affected area before
developing NF.iewed
Pacific Others Total*
(n=60) (n=17) (n=247)
M F M F M F
2 1 0 0 5 4
5 3 0 2 13 11
13 5 2 2 43 23
14 11 7 2 56 35
5 1 1 1 32 24
39 21 10 7 150 97
(65.0) (35.0) (58.8) (41.2) (60.7) (39.3)
Table 2 Presence of known predisposing conditions for NF by ethnicity
Predisposing conditions European
(n=122)
Maori
(n=47)
Pacific
(n=60)
Others
(n=17)
Total
(n=247)
p-
value
No. % No. % No. % No. % No. %
Diabetes mellitus 28 23.0 14 29.8 27 45.0 10 58.8 79 32.0 0.002
Alcohol abuse 11 9.0 3 6.4 0 0.0 1 5.9 15 6.1 0.126
Obesity 23 18.9 16 34.0 14 23.3 3 17.6 56 22.7 0.193
Coronary heart disease 22 18.0 8 17.0 5 8.3 5 29.4 40 16.2 0.156
Congestive heart failure 15 12.3 6 12.8 10 16.7 2 11.8 33 13.4 0.865
Peripheral vascular disease 14 11.5 6 12.8 4 6.7 2 11.8 26 10.5 0.720
Chronic obstructive 16 13.1 4 8.5 2 3.3 0 0.0 22 8.9 0.086
pulmonary disease
Cancer 12 9.8 3 6.4 1 1.7 2 11.8 18 7.3 0.210
Chronic renal failure 11 9.0 9 19.1 7 11.7 2 11.8 29 11.7 0.341
Steroid use 14 11.5 2 4.3 1 1.7 0 0.0 17 6.9 0.040
Non-steroidal anti-inflammatory drug use* 29 23.8 11 23.4 10 16.7 7 41.2 57 23.1 0.208
No condition documented 18 14.8 10 21.3 20 33.3 0 0.0 49 19.8 0.004
*Low-dose Aspirin 100mg/day or less excluded.
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Out of 247 NF patients’ charts reviewed, either debrided
tissue, blood, aspirated fluid or wound swab culture
results (in the form of hard copy or electronic laboratory
reports) were available for 219. Another 19 patients had
their culture results documented in their clinical notes
but no laboratory reports were filed in their charts. Spe-
cimens were taken at operation (debrided tissue or swab)
or preoperatively (blood, blister fluid or wound swab). In
total, there were culture positive results from one or
more specimens in 96% (228/238) patients. The extent
of microbiology investigations and their documentation
in different hospitals were not uniform. For example, the
number of antibiotics against which a cultured organism
was tested for susceptibility differed substantially from
hospital to hospital and also within the hospital from
case to case. We are not sure whether specimens were
cultured for all possible organisms. For example, for
many cases anaerobic culture reports were not available.Table 3 Presence of precipitating events for NF by ethnicity i
Precipitating events European
(n=122)
Maori
(n=47)
No. % No. % N
Traditional tattooing 0 0.0 0 0.0
Accidental trauma 43 35.2 15 31.9 1
Skin ulcer 20 16.4 9 19.1
Surgery 16 13.1 6 12.8
Burns 3 2.5 0 0.0
Current IVDU* 2 1.6 1 2.1
*IVDU= Intravenous drug use.Some reported specific anaerobic organisms isolated
while some indicated that there was growth of mixed
anaerobes. It is also important to note that a third of all
patients received antibiotics before hospital admission
and specimens for culture were taken. Table 4 is a list of
organisms isolated either solely or in combinations, and
their frequency of occurrence.
The most common organism isolated was Streptococcus
pyogenes (41.2%) either solely (20.6%) or in combination
with other organisms (20.6%). Streptococci other than
Streptococcus pyogenes, usually in combination with other
organisms, were isolated in 17.6% cases. For most of the
Streptococcus pyogenes isolates antibiotic susceptibility
testing was not done. The culture reports mentioned that
Streptococcus pyogenes was universally susceptible to
Penicillin.
The second most common organism isolated was
Staphylococcus aureus (31.9%). Most (88.0%) Staphy-
lococcus aureus isolates were resistant to penicillins.n reviewed patients
Pacific
(n=60)
Others
(n=17)
Total
(n=247)
p-
value
o. % No. % No. %
4 6.7 0 0.0 4 1.6 0.005
9 31.7 4 23.5 82 33.2 0.791
5 8.3 4 23.5 39 15.8 0.289
4 6.7 2 11.8 28 11.3 0.619
0 0.0 0 0.0 3 1.2 0.378
0 0.0 0 0.0 3 1.2 0.693
Table 4 Micro-organisms isolated from NF patients for
whom culture results were available (n=238)
Count Percentage
Organisms and characteristics:
• Gram positive cocci
Streptococcus pyogenes 98 41.2%
Other streptococci spp. 42 17.6%
Staphylococcus aureus (SA) 76 31.9%
Other staphylococci spp. 37 15.5%
MRSA 8 3.4%
• Gram positive bacilli
Corynebacterium spp. 5 2.1%
• Mixed gram positive organisms 4 1.7%
• Gram negative bacilli
E coli 23 9.7%
Proteus spp. 8 3.4%
Klebsiella spp. 3 1.3%
Enterobacter spp. 2 0.8%
Serratia spp. 5 2.1%
Citrobacter spp. 1 0.4%
Pseudomona spp. 17 7.1%
Eikenella spp. 1 0.4%
Providencia spp. 1 0.4%
Vibrio spp. 1 0.4%
Stenotrophomonas spp. 2 0.8%
Hafnia spp. 1 0.4%
Aeromonas hydrophilia 1 0.4%
Mixed gram negative bacilli 7 2.9%
• Anaerobes
Bacteroides spp. 11 4.6%
Prevotella spp 3 1.3%
Clostridium spp 2 0.8%
Preptostreptococcus spp. 1 0.4%
Mixed anaerobes 29 12.2%
• Mixed bowel flora 4 1.7%
• Mixed skin flora 7 2.9%
• Fungus
Candida spp. 1 0.4%
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89.8% and 88.6% respectively. Methicillin-resistant
Staphylococcus aureus (MRSA) was cultured in 8 (3.4%)
cases.
The ethnic distribution of patients affected by these
two organisms and the antibiotic susceptibility results
of Staphylococcus aureus to three common antibiotics
(penicillin, erythromycin and flucloxacillin) are presented
in Table 5. Although a higher percentage of Pacific peoplecultured Streptococcus pyogenes and Staphylococcus aureus,
these ethnic differences were not statistically significant.Complication, specific intervention and outcome
Many NF patients developed several complications and
underwent specific interventions during their hospital
stay. Table 6 shows the frequency and ethnic distribution
of some complications (renal failure, shock, multi-organ
dysfunction, coagulation abnormalities and myocardial
infarction), specific interventions (surgical debridement,
skin grafting, blood product transfusion, ICU admission
and dialysis) and two specific outcomes (amputation and
death). The ethnic differences in the extent of complica-
tions, interventions and outcomes were not statistically
significant.
This is the largest NF case-series so far reported and
shows several important features of the risk factors,
microbiology, and outcomes for this infection. Our ana-
lysis confirms the earlier finding of a positive association
of NF with increasing age and with male sex [3]. More
than 80% of patients had one or more recognized predis-
posing conditions. For Europeans and people of Other
ethnicity, two common conditions were diabetes and
NSAID use, while those for Maori and Pacific people
were diabetes and obesity. Increasing rates of diabetes
and obesity in Pacific people and Maori are well docu-
mented [28], and these trends could partly explain the
increasing incidence of NF in recent years [3]. An asso-
ciation has been documented between NF and NSAIDs
and there are plausible mechanisms by which NSAIDs
might predispose to severe bacterial infection [14]. We
found that nearly a quarter of patients had a history
of NSAID use within the seven days preceding onset of
symptoms. This finding is consistent with the results of
two studies from Middlemore Hospital in Auckland
[9,12]. However, the definitive answer regarding the
question of causation has not been resolved [14,29]. As
in other studies [16], we found that accidental trauma,
surgery, ulcer, burn and intra venous drug use (IVDU)
had triggered the process in some cases. A third of
patients had an antecedent history of accidental trauma
(including blunt trauma without a breach in the skin).
Traditional Samoan tattooing was documented as the
precipitating event for NF in four Samoan men, one of
whom died. There were no further details of the process
of tattooing or infection control procedures recorded in
the patient notes, so we cannot implicate any particular
aspect of the procedure as contributing to the risk of
developing the condition. It was reported in two charts
that NF developed at the site of acupuncture. No further
details were available. Although there was considerable
media attention and publicity about the risks from trad-
itional Samoan tattooing, this review found that the
Table 5 Distribution of Streptococcus pyogenes and Staphylococcus aureus (SA) and antibiotic susceptibility pattern of
SA by ethnicity
European Maori Pacific Other Total p-
valueNo. % No. % No. % No. % No. %
Streptococcus pyogenes 48 (n=117) 41.0 18 (n=45) 40.0 28 (n=59) 47.5 4 (n=17) 23.5 98 (n=238) 41.2 0.366
Staphylococcus aureus (SA) 33 (n=117) 28.2 12 (n=45) 26.7 25 (n=59) 42.4 6 (n=17) 35.3 76 (n=238) 31.9 0.224
SA susceptible to Penicillin 5 (n=32) 15.6 1 (n=12) 8.3 3 (n=23) 13.0 0 (n=6) 0.0 9 (n=73) 12.3 0.716
SA susceptible to Erythromycin 23 (n=29) 79.3 12 (n=12) 100.0 21 (n=22) 95.5 6 (n=6) 100.0 62 (n=69) 89.9 0.097
SA susceptible to Flucloxacillin 29 (n=31) 93.5 10 (n=11) 90.9 17 (n=22) 77.3 6 (n=6) 100.0 62 (n=70) 88.6 0.224
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relation to the overall burden of NF. This finding is con-
sistent with the international literature which has
reported only a few sporadic cases of NF following trad-
itional tattooing [17,30]. It is probable that some people
developed less severe forms of infection (e.g. cellulitis)
following traditional tattooing [20]. However, exploration
of those outcomes was not part of this study.
We found that Streptococcus pyogenes, either singly or
in combination with a staphylococcus or other organism,
was the most frequent organism isolated in NF cases.
Fifty-eight percent of culture positive cases in this group
grew Streptococcus pyogenes or a non-Group A strepto-
coccus. This finding is consistent with the microbiology
findings of a case series of 198 necrotizing soft tissue
infections (NSTI) in the US, where a streptococcus was
isolated in 56% of cases [22]. Staphylococcus aureus in-
cluding MRSA was cultured in more than a third of our
reviewed cases for whom a microbiology result was
available. This proportion is higher than that reported
for the other series [9,10,12,16,22]. Only about 10% of
staphylococci were MRSA (8 out of 76). A wide variation
of the proportion of MRSA from NF patients has beenTable 6 Complications, specific interventions and outcomes o
European
(n=122)
Maori
(n=47)
No. % No. %
Renal failure 54 44.3 20 42.6
Shock 54 44.3 17 36.2
Multi-organ dysfunction 21 17.2 8 17.0
Coagulation abnormality 31 25.4 8 17.0
Myocardial infarction 5 4.1 1 2.1
ICU admission 73 59.8 20 42.6
Surgical debridement 109 89.3 44 93.6
Skin grafting 64 52.5 26 55.3
Blood product transfusion 64 52.5 17 36.2
Dialysis 8 6.6 5 10.6
Amputation 22 18.0 5 10.6
Death 33 27.0 8 17.0reported [22,31-33]. Our result is near the lower end of
this range [22,33].
In addition to the above two major organisms, many
others were cultured from reviewed NF patients. This
result is consistent with the findings of the NSTI case
series already mentioned, though the frequencies were
different [22].
Proportions of Pacific people with Streptococcus
pyogenes and Staphylococcus aureus positive culture are
higher (though not significantly) than in all other ethnic
groups. From this limited information, it appears that
staphylococcus may be playing a bigger role in the
pathogenesis of NF in NZ, particularly affecting Pacific
people. This observation might partly explain the
higher rates observed in Pacific people but needs fur-
ther exploration to assess whether it is an important
finding.
Our study documents the severe consequences of NF
in terms of the high proportion with serious complica-
tions and death. We could locate only one other study
reporting the extent of health care resource used to
manage NF [23]. Although some studies reported the
proportion of NF cases resulting in death, limb loss andf NF admission by ethnicity in reviewed patients
Pacific
(n=60)
Other
(n=17)
Total
(n=247)
p-
value
No % No. % No. %
24 40.0 7 41.2 105 42.2 0.957
24 40.0 9 52.9 105 42.5 0.607
12 20.0 3 17.6 44 17.8 0.970
11 18.3 3 17.6 53 21.5 0.539
4 6.7 1 5.9 11 4.5 0.705
35 58.3 10 58.8 138 55.9 0.225
53 88.3 16 94.1 223 90.3 0.739
34 56.7 7 41.2 131 53.0 0.708
25 41.7 9 52.9 115 46.6 0.203
7 11.7 1 5.9 21 8.5 0.618
5 8.3 2 11.8 34 13.8 0.285
12 20.0 5 29.4 58 23.5 0.443
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reported complication rates and specific interventions to
manage these as reported in this current paper.
Our study has important limitations. The NF patient
records reviewed were confined to those admitted to a
sample of NZ hospitals from 2000 to 2006, though it did
include the majority of NF cases discharged over that
seven year period. Consequently, it may not be possible
to generalize our findings to all hospitals in NZ and to
other time periods. This study was also limited to
reviewing data on NF cases and did not include a com-
parison population. As a result, it is difficult to evaluate
the significance of the risk factors which appeared to be
associated with NF, such as diabetes and NSAID use.
Our review of cases was limited to information recorded
in patient notes, so is likely to underestimate the propor-
tions of some characteristics, particularly predisposing
conditions and precipitating events.
Conclusions
From the retrospective chart review results, we conclude
that NF incidence and distribution is strongly influenced
by the presence of various known predisposing condi-
tions which compromise immunity, particularly in the
elderly. Traditional Samoan tattooing and other body
piercing procedures are not major causes. There is also
potentially a contribution from changes in the virulence
of the causative organisms, though we could not assess
this potential factor with the data that were available.
The rising incidence of NF in NZ [3] also needs to be
put in the wider context of a well documented increase
in serious skin infections in children that is caused by
similar bacteria [34]. The incidence of serious infectious
diseases in general has risen significantly in NZ over the
20 year period from 1989 to 2008, as have ethnic and
socio-economic inequalities [35]. These wider changes
suggest that there may also be a contribution to NF from
broad health determinants, such as disparities in income,
housing conditions, and access to health services.
Given the rising incidence of NF in NZ and its sever-
ity, greater effort should be put into preventing this dis-
ease and improving the outcomes for those infected.
Findings from this study suggest that high risk groups
identified here should be the focus of attention. Patients
over 50 years of age with important predisposing condi-
tions (diabetes, obesity) should be alerted to this risk. In
particular, they should take care to protect themselves
from skin trauma and ulcers, and also ensure rapid as-
sessment of skin infections if they develop. Further ana-
lytic studies (probably case–control) should be
considered to quantify the importance of the risk factors
identified here, particularly the role of pharmaceuticals
such as NSAIDs, steroids, and other immune suppres-
sive drugs.Abbreviations
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